Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde inhibits the expression of DME ALDH1B1 |
[1] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Lead |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01505
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Lead inhibits the expression of DME ALDH1B1 |
[2] |
Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME ALDH1B1 |
[3] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Apocarotenal |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01523
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Apocarotenal inhibits the expression of DME ALDH1B1 |
[4] |
Walrycin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01498
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Walrycin A up-regulates the expression of DME ALDH1B1 |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME ALDH1B1 |
[6], [7] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide up-regulates the expression of DME ALDH1B1 |
[8] |
Calcitriol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Calcitriol inhibits the expression of DME ALDH1B1 |
[9] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME ALDH1B1 |
[10] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME ALDH1B1 |
[11] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME ALDH1B1 |
[12] |
Leflunomide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Leflunomide up-regulates the expression of DME ALDH1B1 |
[13] |
Urethane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane inhibits the drug-metabolizing activity of DME ALDH1B1 |
[14] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME ALDH1B1 |
[15] |
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME ALDH1B1 |
[16] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Quercetin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Quercetin inhibits the expression of DME ALDH1B1 |
[17] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME ALDH1B1 |
[18], [19] |
K-7174 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 inhibits the expression of DME ALDH1B1 |
[20] |
|
|
|
|
|
|